NCT07213271 Physical Exercise on Metabolic Health, Gut Microbiota, Physical Fitness, and Quality of Life in Obese Breast Cancer Survivors
| NCT ID | NCT07213271 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Comenius University |
| Condition | Breast Cancer Females |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-03-01 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate whether a 3-month dance-based exercise program combined with individualized nutrition can improve health outcomes in obese breast cancer survivors in remission. The main questions it aims to answer are: Will the intervention reduce body weight, body fat, and visceral adiposity? Will it improve cardiorespiratory fitness, motor performance, gut microbiota composition, and quality of life? Researchers will compare women participating in the dance and nutrition program with a control group who maintain their usual lifestyle to see if the intervention leads to favorable metabolic, physical, and microbiome-related changes. Participants will: Attend supervised dance classes three times per week for 12 weeks. Follow an individualized nutrition plan tailored to their resting metabolic rate. Provide blood and stool samples, complete fitness tests, and answer quality-of-life questionnaires before and after the intervention.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of breast cancer disease * At least one year after breast cancer treatment * Must be able to swallow tablets * Must be able to folow physical exercise training Exclusion Criteria: * Clinical diagnosis of Parkinson's disease * Insulin dependent diabetes * Infectious diseases within the past 2 months * Use of antibiotics within the past 4 weeks before recruitment
Contact & Investigator
Viktor Bielik, PhD
PRINCIPAL INVESTIGATOR
Comenius University, Faculty of Physical Education and Sport
Frequently Asked Questions
Who can join the NCT07213271 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 70 Years, studying Breast Cancer Females. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07213271 currently recruiting?
Yes, NCT07213271 is actively recruiting participants. Contact the research team at libusa.nechalova@uniba.sk for enrollment information.
Where is the NCT07213271 trial being conducted?
This trial is being conducted at Bratislava, Slovakia.
Who is sponsoring the NCT07213271 clinical trial?
NCT07213271 is sponsored by Comenius University. The principal investigator is Viktor Bielik, PhD at Comenius University, Faculty of Physical Education and Sport. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.